ArticleTherapeutic advances in gastroenterology2019

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials.

Brian E Lacy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.